No abstract available
MeSH terms
-
Administration, Inhalation
-
Adolescent
-
Adult
-
Age Factors
-
Anti-Asthmatic Agents / administration & dosage*
-
Anti-Asthmatic Agents / adverse effects
-
Antibodies, Anti-Idiotypic / administration & dosage*
-
Antibodies, Anti-Idiotypic / adverse effects
-
Antibodies, Monoclonal, Humanized / administration & dosage*
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Asthma / drug therapy*
-
Asthma / immunology
-
Child
-
Female
-
Guideline Adherence
-
Humans
-
Male
-
Omalizumab
-
Practice Guidelines as Topic*
-
Risk Assessment
-
Severity of Illness Index
-
Treatment Outcome
-
United Kingdom
-
Young Adult
Substances
-
Anti-Asthmatic Agents
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal, Humanized
-
Omalizumab